ADAPTIN BIO, INC. — Form D/A

ADAPTIN BIO, INC. of CHARLOTTE, NC, a company, filed a Form D amendment with the SEC on 2026-03-23. The offering totals $4.0M, of which $1.7M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-03-23
• Form: D/A
• Accession: 0001938571-26-000003
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $4.0M
• Amount sold: $1.7M
• Remaining: $2.3M
• Investors: 13
• Date of first sale: 2025-12-22
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-568890

Issuer

• Name: ADAPTIN BIO, INC.
• CIK: 0001938571
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 3540 TORINGDON WAY SUITE 200, #250, CHARLOTTE, NC, 28277
• Phone: (888) 609-1498

Officers, directors & promoters (16)

Other filings by this issuer (4)

More

• CIK 1938571 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search